Provides a comprehensive overview of common non-dental facial pain which will be of interest to non-specialist dentists.
Provides guidance with regards to diagnosis, management and when to refer facial pain patients.
Highlights the importance of adopting a biopsychosocial approach to facial pain management
The diagnosis and management of orofacial pain may be challenging due to complex histories, pathophysiology and associated psychosocial co-morbidities such as depression and anxiety. Neuropathic facial pain conditions such as burning mouth syndrome (BMS), persistent idiopathic facial pain (PIFP), atypical odontalgia (AO) and trigeminal neuralgia (TN) require early recognition by primary care clinicians and referral to secondary care. Acute pain-related temporomandibular disorder (TMD) may be managed in the primary care setting, with identification of those at risk of developing chronic TMD receiving an early referral to secondary care. Adopting a biopsychosocial approach, consisting of physical therapies, pharmacotherapy and psychological support can lead to effective management and may limit the negative impact of facial pain upon quality of life and daily functioning.
Subscribe to Journal
Get full journal access for 1 year
only $20.79 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
IASP. Orofacial pain. 2016. Available at https://www.iasp-pain.org/files/Content/ContentFolders/GlobalYearAgainstPain2/20132014OrofacialPain/FactSheets/Orofacial_Pain_2016.pdf (accessed September 2017)
Zakrzewska J M, Hamlyn P J . Facial pain. In Crombie I K, Croft P R C, Linton S J, LeResche M V K (editors) Epidemiology of pain. pp. 171–202. Seattle, Washington: IAS Press, 1999.
Macfarlane A, Blinkhorn A S, Davies R M, Kincey J, Worthington H V . Predictors of Outcome for Orofacial Pain in the General Population: a Four-year Follow-up Study. J Dent Res 2004; 83: 712–717.
Macfarlane T V, Beasley M, Macfarlane G J . Self-Reported Facial Pain in UK Biobank Study: Prevalence and Associated Factors. J Oral Maxillofac Res 2014; 5: e2.
Zakrzewska J M . Orofacial pain Oxford University Press, 2009.
Bonathan C J, Zakrzewska J M, Love J, Williams A C . Beliefs and distress about orofacial pain: patient journey through a specialist pain consultation. J Oral Facial Pain Headache 2014; 28: 223–232.
Shueb S S, Nixdorf D R, John M T, Alonso B F, Durham J . What is the impact of acute and chronic orofacial pain on quality of life? J Dent 2015; 43: 1203–1210.
Aggarwal V, McBeth J, Zakrzewska J, Macfarlane G . Unexplained orofacial pain–is an early diagnosis possible? Br Dent J 2008; 205: E6.
Durham J, Breckons M, Araujo-Soares V, Exley C, Steele J, Vale L . Developing Effective and Efficient care pathways in chronic Pain: DEEP study protocol. BMC Oral Health 2014; 14: 1.
Peters S, Goldthorpe J, McElroy C et al. Managing chronic orofacial pain: A qualitative study of patients', doctors', and dentists' experiences. Br J Health Psychol 2015; 20: 777–791.
Breckons M, Bissett S, Exley C, Araujo-Soares V, Durham J . Care pathways in persistent orofacial pain: qualitative evidence from the DEEP study. JDR Clin Transl Res 2017; 2: 48–57.
Durham J, Shen J, Breckons M, Steele J G, Araujo-Soares V, Exley C et al. Healthcare Cost and Impact of Persistent Orofacial Pain: The DEEP Study Cohort. J Dent Res 2016; 95: 1147–1154.
Von Korff M, Ormel J, Keefe F J, Dworkin S F . Grading the severity of chronic pain. Pain 1992; 50: 133–149.
Price C, Hoggart B, Olukoga O, Williams A, Bottle A . Guidelines for pain management programmes for adults: An evidence-based review prepared on behalf of the British Pain Society. London: The British Pain Society, 2013.
Ghurye S, McMillan R . Pain-Related Temporomandibular Disorder-Current Perspectives and Evidence-Based Management. Dent update 2015; 42: 533–546.
Renton T, Durham J, Aggarwal V R . The classification and differential diagnosis of orofacial pain. Expert Rev Neurother 2012; 12: 569–576.
Lauria G, Majorana A, Borgna M et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005 Jun; 115: 332–337.
Woda A, Dao T, Gremeau-Richard C . Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain 2009; 23: 202–210.
McMillan R, Forssell H, Buchanan J, Glenny A M, Weldon J C, Zakrzewska J M . Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2016: CD002779.
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino M A . Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275–291.
Braud A, Touré B, Agbo-Godeau S, Descroix V, Boucher Y . Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: a pilot study. J Orofac Pain 2013; 27: 235–242.
Bergdahl J, Anneroth G, Perris H . Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 1995; 24: 213–215.
Balasubramaniam R, Klasser G, Delcanho R . Separating oral burning from burning mouth syndrome: unravelling a diagnostic enigma. Aust Dent J 2009; 54: 293–299.
Souza F T, Santos T P, Bernardes V F et al. The impact of burning mouth syndrome on health-related quality of life. Health Qual Life Outcomes 2011; 9: 57.
Maragou P, Ivanyi L . Serum zinc levels in patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1991; 71: 447–450.
Patton L L, Siegel M A, Benoliel R, De Laat A . Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl S39: e1–e13.
Kohorst J J, Bruce A J, Torgerson R R, Schenck L A, Davis M D . The prevalence of burning mouth syndrome: a population-based study. Br J Dermatol 2015; 172: 1654–1656.
Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A . Benzydamine hydrochloride oral rinses in management of burning mouth syndrome: a clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 683–686.
Jääskeläinen S K, Rinne J O, Forssell H et al. Role of the dopaminergic system in chronic pain–a fluorodopa-PET study. Pain 2001; 90: 257–260.
Lamey P-J, Freeman R, Eddie S-A, Pankhurst C, Rees T . Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 48–54.
Taiminen T, Kuusalo L, Lehtinen L et al. Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain. Scand J Pain 2011; 2: 155–160.
Lopez-Jornet P, Camacho-Alonso F, Lucero-Berdugo M . Quality of life in patients with burning mouth syndrome. J Oral Pathol Med 2008; 37: 389–394.
de Iongh A . Patients need support to self manage their long term conditions. BMJ 2014; 348: g2973.
Napenas J J, Nussbaum M L, Eghtessad M, Zakrzewska J M . Patients' satisfaction after a comprehensive assessment for complex chronic facial pain at a specialised unit: results from a prospective audit. Br Dent J 2011; 211: E24.
Bogetto F, Bonatto Revello R, Ferro G, Maina G, Ravizza L . Psychopharmacological treatment of burning mouth syndrome (BMS). A study on a sample of 121 patients. Minerva Psichiatrica 1999; 40: 1–10.
NICE. Neuropathic pain in adults: pharmacological management in nonspecialist settings (CG173). London: National Institute for Health and Care Excellence (NICE), 2013.
Bergdahl J, Anneroth G, Ferris H . Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 1995; 24: 213–215.
Headache Classification Committee of the International Headache S. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629–808.
Renton T . Persistent pain after dental surgery. Rev Pain 2011; 5: 8.
Benoliel R, Gaul C . Persistent idiopathic facial pain. Cephalalgia 2017; 37: 680–691.
Weiss A L, Ehrhardt K P, Tolba R . Atypical Facial Pain: a Comprehensive, Evidence-Based Review. Curr Pain Headache Rep 2017; 21: 8.
Pigg M, Svensson P, Drangsholt M, List T . Seven-year follow-up of patients diagnosed with atypical odontalgia: a prospective study. J Orofac Pain 2013 Spring; 27: 151–164. PubMed PMID: 23630687.
List T, Leijon G, Helkimo M, Öster A, Dworkin S F, Svensson P . Clinical findings and psychosocial factors in patients with atypical odontalgia: a case-control study. J Orofac Pain 2007; 21: 89–98.
Nixdorf D R, Moana-Filho E J, Law A S, McGuire L A, Hodges J S, John M T . Frequency of nonodontogenic pain after endodontic therapy: a systematic review and meta-analysis. J Endod 2010; 36: 1494–1498.
Polycarpou N, Ng Y L, Canavan D, Moles D R, Gulabivala K . Prevalence of persistent pain after endodontic treatment and factors affecting its occurrence in cases with complete radiographic healing. Int Endod J 2005; 38: 169–178.
Baad-Hansen L, Pigg M, Ivanovic S E et al. Chairside intraoral qualitative somatosensory testing: reliability and comparison between patients with atypical odontalgia and healthy controls. J Orofac Pain 2013; 27: 165–170.
Renton T, Yilmaz Z . Profiling of patients presenting with posttraumatic neuropathy of the trigeminal nerve. J Orofac Pain 2011; 25: 333–344.
Forssell H, Jaaskelainen S, List T, Svensson P, Baad-Hansen L . An update on pathophysiological mechanisms related to idiopathic oro-facial pain conditions with implications for management. J Oral Rehabil 2015; 42: 300–322.
Durham J, Wassell R . Recent advancements in temporomandibular disorders (TMDs). Rev Pain 2011; 5: 18.
Dworkin S F, LeResche L . Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992; 6: 301–355.
Durham J A V, Davies S J, Harrison S D et al. Temporomandibular Disorders (TMDs): An update and management guidance for primary care from the UK Specialist Interest Group in Orofacial Pain and TMDs (USOT). Royal College of Surgeons of England: Royal College of Surgeons of England, 2013.
Kermani T A, Schmidt J, Crowson C S et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866–871.
Fillingim R B, Ohrbach R, Greenspan J D et al. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011; 12: T46T60.
Zigmond A S, Snaith R P . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
Crow H, Parks E, Campbell J, Stucki D, Daggy J . The utility of panoramic radiography in temporomandibular joint assessment. Dentomaxillofac Radiol 2005; 34: 91–95.
Epstein J B, Caldwell J, Black G . The utility of panoramic imaging of the temporomandibular joint in patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 236–239.
Ribeiro-Rotta R, Marques K, Pacheco M, Leles C . Do computed tomography and magnetic resonance imaging add to temporomandibular joint disorder treatment? A systematic review of diagnostic efficacy. J Oral Rehabil 2011; 38: 120–135.
Dworkin S F . The OPPERA study: act one. J Pain 2011; 12(11 Suppl): T1–T3.
Maixner W, Diatchenko L, Dubner R et al. Orofacial pain prospective evaluation and risk assessment study–the OPPERA study. J Pain 2011; 12(11 Suppl): T4.
Ohrbach R, Dworkin S F . Five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables. Pain 1998; 74: 315–26.
Slade G D, Bair E, Greenspan J D et al. Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study. J Pain 2013; 14(12 Suppl): T20–T32.
Litt M D, Porto F B . Determinants of pain treatment response and nonresponse: identification of TMD patient subgroups. J Pain 2013; 14: 1502–1513.
Benoliel R, Svensson P, Heir G M et al. Persistent orofacial muscle pain. Oral Dis 2011; 17 Suppl 1: 23–41.
Fernández-de-Las-Peñas C, Svensson P . Myofascial Temporomandibular Disorder. Curr Rheumatol Rev 2016; 12: 40–54.
Woolf C J . Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152(3 Suppl): S2–S15.
Goldthorpe J, Lovell K, Peters S et al. A Pilot Randomized Controlled Trial of a Guided Self-Help Intervention to Manage Chronic Orofacial Pain. J Oral Facial Pain Headache 2017; 31: 61–71.
Villemure C, Ceko M, Cotton V A, Bushnell M C . Insular cortex mediates increased pain tolerance in yoga practitioners. Cereb Cortex 2014; 24: 2732–2740.
Oral A, Ilieva E, Küçükdeveci A et al. Generalised and regional soft tissue pain syndromes. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee. Eur J Phys Rehabil Med 2013; 49: 535–549.
Michelotti A, Iodice G, Vollaro S, Steenks M H, Farella M . Evaluation of the short-term effectiveness of education versus an occlusal splint for the treatment of myofascial pain of the jaw muscles. J Am Dent Assoc 2012; 143: 47–53.
Carlson C R, Bertrand P M, Ehrlich A D, Maxwell A W, Burton R G . Physical self-regulation training for the management of temporomandibular disorders. J Orofac Pain 2001; 15: 47–55.
Mujakperuo H R, Watson M, Morrison R, Macfarlane T V . Pharmacological interventions for pain in patients with temporomandibular disorders. Cochrane Database Syst Rev 2010; CD004715.
Hersh E V, Balasubramaniam R, Pinto A . Pharmacologic management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am 2008; 20: 197–210.
Fricton J, Look J O, Wright E et al. Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders. J Orofac Pain 2010; 24: 237.
Klasser G D, Greene C S . Oral appliances in the management of temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 212–223.
Gesch D, Bernhardt O, Kirbschus A . Association of malocclusion and functional occlusion with temporomandibular disorders (TMD) in adults: a systematic review of population-based studies. Quintessence Int 2004; 35: 211–221.
Luther F, Layton S, McDonald F . Orthodontics for treating temporomandibular joint (TMJ) disorders. Cochrane Database Syst Rev 2010; CD006541.
Ihde S K, Konstantinovic V S . The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: e1–e11.
Ernberg M, Hedenberg-Magnusson B, List T, Svensson P . Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain 2011; 152: 1988–1996.
Vos L M, Huddleston Slater J, Stegenga B . Lavage therapy versus nonsurgical therapy for the treatment of arthralgia of the temporomandibular joint: a systematic review of randomized controlled trials. J Orofac Pain 2013; 27: 171–179.
Rigon M, Pereira L M, Bortoluzzi M C, Loguercio A D, Ramos A L, Cardoso J R . Arthroscopy for temporomandibular disorders. Cochrane Database Syst Rev 2011; CD006385.
NICE. Total prosthetic replacement of the temporomandibular joint. pp. 1–8. London: National Institute for Health and Clinical Excellence, 2015.
Tölle T, Dukes E, Sadosky A . Patient Burden of Trigeminal Neuralgia: Results from a Cross-Sectional Survey of Health State Impairment and Treatment Patterns in Six European Countries. Pain Pract 2006; 6: 153–160.
Zakrzewska J M, Linskey M E . Trigeminal neuralgia. BMJ 2014; 348: g474.
Headache Classification Subcommittee of the International Headache S. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24 Suppl 1: 9–160.
Cruccu G, Finnerup N B, Jensen T S et al. Trigeminal neuralgia: New classification and diagnostic grading for practice and research. Neurology 2016 Jul 12; 87: 220–228.
Padfield D . The Patient's Journey Through Trigeminal Neuralgia. Pain Clin Updates 2014; 22: 1–8.
McMillan R . Trigeminal Neuralgia—A Debilitating Facial Pain. Rev Pain 2011; 5: 26.
Cruccu G, Gronseth G, Alksne J et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013–1028.
Hall G C, Carroll D, Parry D, McQuay H J . Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006; 122: 156–162.
Di Stefano G, La Cesa S, Truini A, Cruccu G . Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 2014; 15: 34.
Devor M, Amir R, Rappaport Z H . Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 2002; 18: 4–13.
Gronseth G, Cruccu G, Alksne J et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71: 1183–1190.
Kaniwa N, Saito Y . The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review. Ther Adv Drug Saf 2013; 4: 246–253.
Zakrzewska J M, Palmer J, Morisset V et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol 2017; 16: 291–300.
Zakrzewska J M, Palmer J, Ettlin D A et al. Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia. Trials 2013; 14: 1.
Zakrzewska J M, Patsalos P N . Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 2002; 95: 259–266.
Taylor J C, Brauer S, Espir M L . Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J 1981; 57: 16–18.
Allsop M J, Twiddy M, Grant H et al. Diagnosis, medication, and surgical management for patients with trigeminal neuralgia: a qualitative study. Acta Neurochir (Wien) 2015; 157: 1925–1933.
Spatz A, Zakrzewska J, Kay E . Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 2007; 131: 302–310.
Zakrzewska J M, Wu J, Mon-Williams M, Phillips N, Pavitt S H . Evaluating the impact of trigeminal neuralgia. Pain 2017; 158: 1166–1174.
Feinmann C, Newton-John T . Psychiatric and psychological management considerations associated with nerve damage and neuropathic trigeminal pain. J Orofac Pain 2004; 18: 360–365.
Zakrzewska J M, Jorns T P, Spatz A . Patient led conferenceswho attends, are their expectations met and do they vary in three different countries? Eur J Pain 2009; 13: 486–491.
About this article
Cite this article
Ghurye, S., McMillan, R. Orofacial pain – an update on diagnosis and management. Br Dent J 223, 639–647 (2017). https://doi.org/10.1038/sj.bdj.2017.879
British Dental Journal (2020)
Study of the Clinical Efficiency of an Interdisciplinary Approach to the Treatment of Orofacial Pain and Temporomandibular Joint Disorders in Patients with Complete or Partial Edentulism
European Journal of Dentistry (2020)
ASSESSMENT OF THE REHABILITATION EFFICIENCY OF PATIENTS WITH A TEMPOROMANDIBULAR JOINT DYSFUNCTION REQUIRING A FULL-MOUTH RECONSTRUCTION: CONDILOGRAPHY AND ELECTRONEUROMYOGRAPHY METHODS
Actual problems in dentistry (2020)
THE QUALITY OF LIFE OF PATIENTS WITH SYMPTOMS OF TEMPOROMANDIBULAR DISORDER IN INTEGRATED DENTAL ORTHOPEDIC REHABILITATION
Actual problems in dentistry (2020)
Oral Surgery (2020)